Tax Benefit Amount
Edwards Lifesciences·Geographic·1 segment·Rolls up to Deferred Tax Assets, Operating Loss Carryforwards
Breakdown
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Other countries | $60.10M | $65.50M | $71.60M | $89.30M | $104.50M |
| Total | — | — | — | — | — |
Segments
Other countriesView metric